跳至主要内容
临床试验/NCT01953575
NCT01953575已完成不适用

Mucosal Impedance in Eosinophilic Esophagitis and the Effect of Treatment

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2013年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Mayo Clinic
入组人数
30
试验地点
1
主要终点
Esophageal Mucosal Impedance (MI)

研究概览

简要总结

Do patients with eosinophilic esophagitis have baseline increased esophageal mucosal impedance?

And will treatment that reverses esophageal eosinophilia in patients, correct abnormalities in mucosal impedance?

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Adults ages 18-90 undergoing clinically indicated upper endoscopy
  • •Patients with EoE, defined as dysphagia with histologic finding of greater than or equal to 15 eosinophils per high powered field on esophageal biopsy despite at least 6 weeks of twice daily proton pump inhibitor therapy
  • •Patients undergoing clinically indicated upper endoscopy for indications other than dysphagia or Gastroesophageal reflux disease (GERD) with normal appearing esophageal mucosa.

排除标准

  • •Medical conditions such as severe heart or lung disease that preclude safe performance of endoscopy
  • •Patients with conditions known to be associated with esophageal eosinophilia, including Crohn's disease, Churg-Strauss, achalasia, and hypereosinophilic syndrome
  • •Inability to read due to: Blindness, cognitive dysfunction, or English language illiteracy

研究组 & 干预措施

Active Eosinophilic Esophagitis

Experimental

Subjects with an eosinophil count greater than 15 eosinophil per high-powered field (Eos/HPF) and do not have trouble swallowing during the clinical endoscopy

干预措施: Mucosal Impedance (Device)

Active Eosinophilic Esophagitis

Experimental

Subjects with an eosinophil count greater than 15 eosinophil per high-powered field (Eos/HPF) and do not have trouble swallowing during the clinical endoscopy

干预措施: Upper Endoscopy (Procedure)

Inactive Eosinophilic Esophagitis

Experimental

Subjects with an eosinophil count less than 15 eosinophil per high-powered field (Eos/HPF) and do not have trouble swallowing during the clinical endoscopy

干预措施: Mucosal Impedance (Device)

Inactive Eosinophilic Esophagitis

Experimental

Subjects with an eosinophil count less than 15 eosinophil per high-powered field (Eos/HPF) and do not have trouble swallowing during the clinical endoscopy

干预措施: Upper Endoscopy (Procedure)

Control group

Placebo Comparator

Subjects are those undergoing clinically indicated upper endoscopy for nonesophageal symptoms in whom a normal-appearing esophagus was found at the time of endoscopy

干预措施: Upper Endoscopy (Procedure)

结局指标

主要结局

Esophageal Mucosal Impedance (MI)

时间窗: baseline to one year

An endoscopically placed probe measured electrical impedance of the esophageal lining by direct mucosal contact. Impedance measurements of the esophageal mucosa were expressed in ohms as the ratio of voltage to current Impedance measurements were obtained at 2, 5, 10, and 15 cm above the gastroesophageal junction.

次要结局

未报告次要终点

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

David A. Katzka

Principal Investigator

Mayo Clinic

研究点 (1)

Loading locations...

相似试验